Results 191 to 200 of about 166,918 (340)

An Update on Novel Pharmacotherapies for the Treatment of Neuroendocrine Tumors. [PDF]

Int J Mol Sci
Choucair K, Odabashian R, Reddy SN, Azmi AS, Saif MW.   +4 more
europepmc   +1 more source

Extensive glandular and neuroendocrine differentiation of a malignant peripheral nerve sheath tumor in a neurofibromatosis-1 patient

, 2022
Julie Huss-Bawab, Jennifer Sakioka, Nishant Tiwari, Vernon T. Tolo, Amit Sura, Ramzi Bawab, Brian Y. Cooper, Shengmei Zhou, Di Tian, Nick Shillingford   +9 more
openalex   +1 more source

Clinical Application of Positron Emission Tomography/Magnetic Resonance Imaging in Pelvic Malignant Tumors

iRADIOLOGY, EarlyView.
The article reviews the application of positron emission tomography/magnetic resonance imaging (PET/MRI) in pelvic tumors such as endometrial cancer, cervical cancer, ovarian cancer, prostate cancer, and bladder cancer. We summarize the comparative studies on the clinical application between PET/CT and PET/MRI to highlight the advantages and ...
Hui Yang, Jielin Bai, Xuena Li, Yaming Li, Bulin Du, Yan Cui, Shu Wang, Yuxiang Wang   +7 more
wiley   +1 more source

New Treatment Options for Pancreatic Neuroendocrine Tumors: A Narrative Review. [PDF]

Cancers (Basel)
Romanowicz A, Fudalej M, Asendrych-Woźniak A, Badowska-Kozakiewicz A, Nurzyński P, Deptała A.   +5 more
europepmc   +1 more source

Data from Cotargeting the PI3K and RAS Pathways for the Treatment of Neuroendocrine Tumors

, 2023
Joseph Valentino, Jing Li, Yekaterina Y. Zaytseva, W. Conan Mustain, Victoria A. Elliott, Ji Tae Kim, Jennifer W. Harris, Katherine Campbell, Helen A. Weiss, Chi Wang, Jun Song, Lowell Anthony, Courtney M. Townsend, B. Mark Evers   +13 more
openalex   +1 more source

Clinical Implications of Ki‐67 Index, Grade and Hormonal Changes in Pancreatic Neuroendocrine Tumors: Insights Into Tumor Heterogeneity Based on Primary and Secondary Lesions

Journal of Hepato-Biliary-Pancreatic Sciences, EarlyView.
ABSTRACT Background Pancreatic neuroendocrine tumors (PanNETs) show heterogeneity, including temporal shifts in proliferation and hormone production; however, their clinical implications remain uncertain. Methods This retrospective study included 114 patients with metastatic or recurrent PanNETs at Kyushu University Hospital.
Masatoshi Murakami, Nao Fujimori, Kazuhide Matsumoto, Keijiro Ueda, Kohei Nakata, Masafumi Nakamura, Takeo Yamamoto, Yoshinao Oda, Tetsuhide Ito, Yoshihiro Ogawa   +9 more
wiley   +1 more source

Suppl-Figure 2 from Pancreatic Neuroendocrine Tumors and EMT Behavior Are Driven by the CSC Marker DCLK1

, 2023
Yu Ikezono, Hironori Koga, Jun Akiba, Mitsuhiko Abe, Takafumi Yoshida, Fumitaka Wada, Tõru Nakamura, Hideki Iwamoto, Atsutaka Masuda, Takahiko Sakaue, Hirohisa Yano, Osamu Tsuruta, Takuji Torimura   +12 more
openalex   +1 more source

Molecular theranostics: principles, challenges and controversies

Journal of Medical Radiation Sciences, Volume 72, Issue 1, Page 156-164, March 2025.
Molecular theranostics offers a powerful tool to drive precision medicine in nuclear oncology. While theranostics is not a new principle in nuclear medicine, recent advances in instrumentation and radiopharmacy have driven a reinvigoration and a broader suite of applications.
Geoffrey Currie
wiley   +1 more source

Progression of intracardiac metastases from gastroenteropancreatic neuroendocrine tumors. [PDF]

Nucl Med Commun
Abdelfattah FE, Scalia IG, Ibrahim OH, Farina JM, Sonbol MB, Connolly HM, Pellikka PA, Arsanjani R, Yang M, Ayoub C.   +9 more
europepmc   +1 more source

Molecular Imaging and Therapy of Neuroendocrine Tumors

, 2023
Saima Muzahir, Erin Grady
openalex   +2 more sources